Literature DB >> 25344197

Chromoblastomycosis by Cladophialophora carrionii associated with squamous cell carcinoma and review of published reports.

O Carolina Rojas1, Gloria M González, María Moreno-Treviño, Julio Salas-Alanis.   

Abstract

Chromoblastomycosis is a subcutaneous, chronic, granulomatous mycosis that occurs more frequently in tropical and subtropical countries. We describe a case of a 63-year-old male patient with diagnosis of chromoblastomycosis by Cladophialophora carrionii with an 18-year evolution who developed a lethal squamous cell carcinoma.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25344197     DOI： 10.1007/s11046-014-9824-7

Source DB:  PubMed          Journal:  Mycopathologia        ISSN： 0301-486X            Impact factor:   2.574


  16 in total

1.  Chromoblastomycosis associated with a lethal squamous cell carcinoma.

Authors:  Edoardo Torres; Javier Gil Beristain; Zahide Lievanos; Roberto Arenas
Journal:  An Bras Dermatol       Date:  2010 Mar-Apr       Impact factor: 1.896

2.  Molecular diversity of Cladophialophora carrionii in patients with chromoblastomycosis in Venezuela.

Authors:  Gloria M González; O Carolina Rojas; Virgilio Bocanegra-García; J Gerardo González; Elvira Garza-González
Journal:  Med Mycol       Date:  2012-06-27       Impact factor: 4.076

3.  Malignant change (squamous carcinoma) in chronic chromoblastomycosis.

Authors:  H M Foster; T J Harris
Journal:  Aust N Z J Surg       Date:  1987-10

4.  Epidermoid carcinoma arising in extensive chromoblastomycosis.

Authors:  R M Caplan
Journal:  Arch Dermatol       Date:  1968-01

5.  Chromoblastomycosis: clinical and mycologic experience of 51 cases.

Authors:  A Bonifaz; E Carrasco-Gerard; A Saúl
Journal:  Mycoses       Date:  2001       Impact factor: 4.377

6.  Fonsecaea nubica sp. nov, a new agent of human chromoblastomycosis revealed using molecular data.

Authors:  M J Najafzadeh; J Sun; V Vicente; L Xi; A H G Gerrits van den Ende; G S de Hoog
Journal:  Med Mycol       Date:  2010-09       Impact factor: 4.076

7.  Melanoma in a long-standing lesion of chromoblastomycosis.

Authors:  Airton dos Santos Gon; Lorivaldo Minelli
Journal:  Int J Dermatol       Date:  2006-11       Impact factor: 2.736

8.  Chromoblastomycosis with malignant transformation and cutaneous-synovial secondary localization. The potential therapeutic role of itraconazole.

Authors:  C Paul; B Dupont; G Pialoux; M F Avril; R Pradinaud
Journal:  J Med Vet Mycol       Date:  1991

Review 9.  Treating chromoblastomycosis with systemic antifungals.

Authors:  Alexandro Bonifaz; Vanessa Paredes-Solís; Amado Saúl
Journal:  Expert Opin Pharmacother       Date:  2004-02       Impact factor: 3.889

10.  Chromoblastomycosis in Nepal: a study of 13 cases.

Authors:  Seema V Pradhan; O P Talwar; Arnab Ghosh; Ravi M Swami; K C Shiva Raj; Sanjeev Gupta
Journal:  Indian J Dermatol Venereol Leprol       Date:  2007 May-Jun       Impact factor: 2.545
View more
  4 in total

Review 1.  Chromoblastomycosis.

Authors:  Flavio Queiroz-Telles; Sybren de Hoog; Daniel Wagner C L Santos; Claudio Guedes Salgado; Vania Aparecida Vicente; Alexandro Bonifaz; Emmanuel Roilides; Liyan Xi; Conceição de Maria Pedrozo E Silva Azevedo; Moises Batista da Silva; Zoe Dorothea Pana; Arnaldo Lopes Colombo; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

Review 2.  Chromoblastomycosis in India: Review of 169 cases.

Authors:  Reshu Agarwal; Gagandeep Singh; Arnab Ghosh; Kaushal Kumar Verma; Mragnayani Pandey; Immaculata Xess
Journal:  PLoS Negl Trop Dis       Date:  2017-08-03

Review 3.  Chromoblastomycosis: an etiological, epidemiological, clinical, diagnostic, and treatment update.

Authors:  Arival Cardoso de Brito; Maraya de Jesus Semblano Bittencourt
Journal:  An Bras Dermatol       Date:  2018 Jul-Aug       Impact factor: 1.896

Review 4.  Reviewing the Etiologic Agents, Microbe-Host Relationship, Immune Response, Diagnosis, and Treatment in Chromoblastomycosis.

Authors:  Luiz Felipe Domingues Passero; Italo Novais Cavallone; Walter Belda
Journal:  J Immunol Res       Date:  2021-11-01       Impact factor: 4.818
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.